Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2407367
Max Phase: Preclinical
Molecular Formula: C24H37N3O5
Molecular Weight: 447.58
Molecule Type: Small molecule
Associated Items:
ID: ALA2407367
Max Phase: Preclinical
Molecular Formula: C24H37N3O5
Molecular Weight: 447.58
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC[C@H](C)[C@H](NC(=O)[C@@H]([C@@H](O)c1ccccc1)N1CN(C)[C@@H](CC(C)C)C1=O)C(=O)OC
Standard InChI: InChI=1S/C24H37N3O5/c1-7-16(4)19(24(31)32-6)25-22(29)20(21(28)17-11-9-8-10-12-17)27-14-26(5)18(23(27)30)13-15(2)3/h8-12,15-16,18-21,28H,7,13-14H2,1-6H3,(H,25,29)/t16-,18-,19-,20+,21-/m0/s1
Standard InChI Key: CQUYQMVMOCPRIS-BWUHRYBWSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 447.58 | Molecular Weight (Monoisotopic): 447.2733 | AlogP: 1.94 | #Rotatable Bonds: 10 |
Polar Surface Area: 99.18 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 8 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 12.37 | CX Basic pKa: 4.74 | CX LogP: 2.80 | CX LogD: 2.79 |
Aromatic Rings: 1 | Heavy Atoms: 32 | QED Weighted: 0.53 | Np Likeness Score: 0.76 |
1. Mostardeiro MA, Ilha V, Dahmer J, Caro MS, Dalcol II, da Silva UF, Morel AF.. (2013) Cyclopeptide alkaloids: stereochemistry and synthesis of the precursors of discarines C and D and myrianthine A., 76 (7): [PMID:23819826] [10.1021/np400313w] |
Source(1):